[go: up one dir, main page]

WO2003008567A1 - Virus proliferant dans des cellules cancereuses et exprimant efficacement le facteur inhibiteur d'angiogenese tumorale, et utilisations associees - Google Patents

Virus proliferant dans des cellules cancereuses et exprimant efficacement le facteur inhibiteur d'angiogenese tumorale, et utilisations associees Download PDF

Info

Publication number
WO2003008567A1
WO2003008567A1 PCT/CN2002/000352 CN0200352W WO03008567A1 WO 2003008567 A1 WO2003008567 A1 WO 2003008567A1 CN 0200352 W CN0200352 W CN 0200352W WO 03008567 A1 WO03008567 A1 WO 03008567A1
Authority
WO
WIPO (PCT)
Prior art keywords
tumor
inhibitory factor
angiogenesis inhibitory
tumor cells
expressed efficiently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2002/000352
Other languages
English (en)
Chinese (zh)
Inventor
Qijun Qian
Xiaoyan Che
Shuntong Shan
Mengchao Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2003008567A1 publication Critical patent/WO2003008567A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention concerne un virus proliférant dans des cellules cancéreuses et exprimant efficacement le facteur inhibiteur de l'angiogénèse tumorale, ainsi que des utilisations associées. Le virus peut proliférer dans des cellules cancéreuses, sensiblement limité à ne proliférer que dans ce type de cellules, et tue directement ces cellules par suite de l'insertion dans une région non essentielle de son génome de la séquence nucléotidique du facteur inhibiteur de l'angiogénèse. Le nombre de copies du facteur inhibiteur de l'angiogénèse augmente avec la prolifération du virus se reproduisant dans les cellules cancéreuses. Le facteur inhibiteur de l'angiogénèse est ainsi exprimé de façon efficace dans des cellules cancéreuse et permet d'inhiber l'angiogénèse tumorale, la néoplasie, le développement et les métastases.
PCT/CN2002/000352 2001-05-25 2002-05-24 Virus proliferant dans des cellules cancereuses et exprimant efficacement le facteur inhibiteur d'angiogenese tumorale, et utilisations associees Ceased WO2003008567A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN01113003.2 2001-05-25
CN 01113003 CN1397641A (zh) 2001-05-25 2001-05-25 表达血管生成抑制因子的肿瘤细胞内增殖的病毒及其构建方法

Publications (1)

Publication Number Publication Date
WO2003008567A1 true WO2003008567A1 (fr) 2003-01-30

Family

ID=4659748

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2002/000352 Ceased WO2003008567A1 (fr) 2001-05-25 2002-05-24 Virus proliferant dans des cellules cancereuses et exprimant efficacement le facteur inhibiteur d'angiogenese tumorale, et utilisations associees

Country Status (2)

Country Link
CN (1) CN1397641A (fr)
WO (1) WO2003008567A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101248912B1 (ko) * 2009-12-31 2013-03-29 한양대학교 산학협력단 항혈관신생 활성을 가지는 재조합 아데노바이러스

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999023105A1 (fr) * 1997-11-03 1999-05-14 Human Genome Sciences, Inc. Vegi, un inhibiteur de l'angiogenese et de la croissance tumorale

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999023105A1 (fr) * 1997-11-03 1999-05-14 Human Genome Sciences, Inc. Vegi, un inhibiteur de l'angiogenese et de la croissance tumorale

Also Published As

Publication number Publication date
CN1397641A (zh) 2003-02-19

Similar Documents

Publication Publication Date Title
CA2185712A1 (fr) Transfert d'adn par mediation virale renforcee
AU2003297649A1 (en) High efficiency, monolithic multijunction solar cells containing lattice-mismatched materials and methods of forming same
WO2006006948A3 (fr) Methodes et compositions permettant de selectionner des arnsi presentant une fonctionnalite amelioree
EP2281897A3 (fr) Virus mutant oncolytique de l'Herpes Simplex
EA200601231A1 (ru) Дефинитивная энтодерма
WO2008140621A3 (fr) Virus oncolytiques transgéniques et leurs utilisations
WO2002006457A3 (fr) Genes de lipase
AU769385C (en) Virus envelope vector for gene transfer
WO2003038076A1 (fr) Cellules mesenchymateuses immortalisees et leur utilisation
EP0999279A4 (fr) Procede de transfert de genes a l'aide d'un milieu exempt de serum
EP1678315A4 (fr) Proteines a doigt de zinc issues du genie genetique pour la regulation de l'expression genique
HUP0000992A3 (en) Genetically engineered cell culture adapted infections bursal diseases virus (ibdv) mutants
AU2149099A (en) Pseudo-type retroviral vectors with modifiable surface capsid proteins
WO2006096989A3 (fr) Vecteurs d'expression pour l'expression genetique transitoire et cellules mammaliennes les exprimant
WO2003008567A1 (fr) Virus proliferant dans des cellules cancereuses et exprimant efficacement le facteur inhibiteur d'angiogenese tumorale, et utilisations associees
WO2003054160A3 (fr) Lignees cellulaires a virus de l'immunodeficience latent, et procedes d'utilisation
WO2002094983A3 (fr) Complexes d'anticorps d'adn pour renforcer le transfert genique
WO2004044182A3 (fr) Lignees cellulaires hautement permissives pour replication de l'arn du virus de l'hepatite c
WO2002100898A3 (fr) Polypeptide a activite entretenant la proliferation ou la survie des cellules souches hematopoietiques et des progeniteurs hematopoietiques, et adn codant ce polypeptide
CN1478143A (zh) 高效表达肿瘤血管生成抑制因子的肿瘤细胞内特异性增殖的病毒及其用途
DE60327536D1 (de) Infektiöse hepacivirus-pseudopartikel mit funktionellen e1-, e2-hüllproteinen
WO1999053085A3 (fr) Regulation selective de la production d'adenovirus
GR3031474T3 (en) DNA ENCODING PRECURSOR OF INTERLEUKIN-1-g(b) CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICE rel?-III)
WO2002004595A3 (fr) Production de papillomavirus humain chimerique
AU4771600A (en) Cells, culture methods and their uses

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP